Alternative and complementary cancer therapies
1996; Wiley; Volume: 77; Issue: 6 Linguagem: Inglês
10.1002/(sici)1097-0142(19960315)77
ISSN1097-0142
AutoresB. R. Cassileth, Christopher C. Chapman,
Tópico(s)Herbal Medicine Research Studies
ResumoCancerVolume 77, Issue 6 p. 1026-1034 CommentaryFree Access Alternative and complementary cancer therapies Barrie R. Cassileth Ph.D., Corresponding Author Barrie R. Cassileth Ph.D. Department of Medicine, University of North Carolina, Chapel Hill, North Carolina Duke University, Durham, North Carolina8033 Old NC 86, Chapel Hill, NC 27516===Search for more papers by this authorChristopher C. Chapman B.A., Christopher C. Chapman B.A. Department of Medicine, University of North Carolina, Chapel Hill, North CarolinaSearch for more papers by this author Barrie R. Cassileth Ph.D., Corresponding Author Barrie R. Cassileth Ph.D. Department of Medicine, University of North Carolina, Chapel Hill, North Carolina Duke University, Durham, North Carolina8033 Old NC 86, Chapel Hill, NC 27516===Search for more papers by this authorChristopher C. Chapman B.A., Christopher C. Chapman B.A. Department of Medicine, University of North Carolina, Chapel Hill, North CarolinaSearch for more papers by this author First published: 15 March 1996 https://doi.org/10.1002/(SICI)1097-0142(19960315)77:6 3.0.CO;2-FCitations: 88AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Begley S, Rosenberg D. Helping docs mind the body. Newsweek 1993, March 8, p 61. 2 Alternative medicine: Implications for clinical practice. Conference sponsored by Harvard Medical School and Beth Israel Hospital, Boston, March 30-April 1, 1995. 3 Mason M. Centering on alternatives. Washington Post 1995, April 3, Section E, p 1. 4 Daly D. Alternative medicine courses taught at U.S. medical schools: an ongoing listing. J Alt Comp Med 1995; 1: 111– 3. 5 Moffet HH. Alternative medicine and managed care: are we making any progress? Alt Comp Ther 1994, October, pp 14– 8. 6 Carton B. Health insurers embrace eye-of-newt therapy. Wall Street Journal 1995, January 30, Section B, p 1. 7 Bokran J, Neher JO, Anson O, Smoker B. Referrals for alternative therapies. J Fam Pract 1994; 39: 545– 50. 8 Cassileth BR, Lusk EJ, Strouse TB, Bodenheimer BJ. Contemporary unorthodox treatments in cancer medicine: a study of patients, treatments and practitioners. Ann Intern Med 1984; 101: 105– 12. 9 Eisenberg DM, Kessler RC, Foster C, Novlock FE, Calkins DR, Delblanco TL, et al. Unconventional medicine in the United States. N Engl J Med 1993; 328: 246– 52. 10 Lerner IJ, Kennedy BJ. The prevalence of questionable methods of cancer treatment in the United States. CA 1992; 42: 181– 91. 11 Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, Lister TA, et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. Br Med J 1994; 309: 86– 9. 12 Pawlicki M, Rachtan J, Rolski J, Sliz E. Results of delayed treatment patients with malignant tumors of the lymphatic system. Pol Tyg Lek 1991; 46: 922– 3. 13 Boisset M, Fitzcharles MA. Alternative medicine use by rheumatology patients in a universal health care setting. J Rheumatol 1994; 21: 148– 52. 14 Sawyer MF, Gannoni AF, Toogood IR Antoniou G, Rice M. The use of alternative therapies by children with cancer. Med J Aust 1994; 160: 320– 2. 15 Van der Zouwe N, van Dam FS, Aaronson NK, Hanewald GJ. Alternative treatments in cancer; extent and background of utilization. Ned Tijdschr Geness Kd 1994; 138: 300– 6. 16 Workshop on Alternative Medicine. Alternative medicine: expanding medical horizons. A report to the National Institutes of Health on alternative medical systems and practices in the United States, Washington, DC: U.S. Government Printing Office, 1992. 17 Cassileth BR. After laetrile, what? N Engl J Med 1982; 306: 1482– 4. 18 Stevenson C. All things considered. Nurs Times 1995; 91: 44– 45. 19 Greenwald P, Clifford C, Pilch S, Heimendinger J, Kelloff G. New directions in dietary studies in cancer: the National Cancer Institute. Adv Exp Med Biol 1995; 369: 229– 39. 20 Kampman E, Verhoeven D, Sloots L, van't Veer P. Vegetable and animal products as determinants of colon cancer risk in Dutch men and women. Cancer Causes Control 1995; 6: 225– 34. 21 Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC, et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 1993; 85: 1571– 9. 22 Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites and Asians in the United States and Canada. J Natl Cancer Inst 1995; 87: 652– 61. 23 Foerster SB, Kizer KW, Disogra LK, Bal DG, Krieg BF, Bunch KL. California's "5 a day–for better health:" campaign: an innovative population-based effort to effect large-scale dietary change. Am J Prevent Med 1995; 1: 124– 31. 24 Kushi M: The macrobiotic approach to cancer. Wayne, NJ: Avery Publishing Group, 1982. 25 Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995; 333: 276– 82. 26 Penn ND, Purkins L, Kelleher J, Heatley RV, Mascie-Taylor BH, Belfield PW. The effect of dietary supplementation with vitamins A, C and E on cell-mediated immune function in elderly long-stay patients: a randomized controlled trial. Age Ageing 1991; 20: 169– 74. 27 Prabhala RH, Braune LM, Garewal HS, Watson RR. Influence of beta-carotene on immune functions. Ann NY Acad Sci 1993; 691: 262– 3. 28 Kabat-Zinn J, Massion A, Kristeller J, Peterson L, Fletcher K, Pbert L, et al. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am J Psychiatr 1992; 149: 936– 43. 29 Benson HR, Lehmann JW, Malhotra MS, Goldman RF, Hopkins J, Epstein MD. Body temperature changes during the practice of gTum-mo yoga. Nature 1982; 295: 234– 6. 30 Schwartz MS. Biofeedback: a practitioner's guide. New York: Guilford Press, 1987. 31 Cassileth BR. The social implications of mind-body cancer research. Cancer Invest 1989; 7: 361– 4. 32 Spiegel D, Bloom JR, Kraemer H, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989; ii: 888. 33 Byrd RC. Positive therapeutic effects of intercessory prayer in a coronary care unit population. South Med J 1988; 81: 826– 29. 34 Dossey L. Meaning and medicine. New York: Bantam Books, 1991. 35 Siegel BS. Love, medicine, and miracles: lessons learned about self-healing from a surgeon's experience. New York: Harper and Row, 1986. 36 Konner M. Medicine at the crossroads. New York: Pantheon, 1993. 37 Gellert GA, Maxwell RM, Siegel BS. Survival of breast cancer patients receiving adjunctive psychosocial support therapy: a 10-year follow-up study. J Clin Oncol 1993; 11: 66– 9. 38 Burton Goldberg Group. Alternative medicine: the definitive guide. Puyallup, WA: Future Publishing, 1993. 39 Chopra D: Ageless body, timeless mind. New York: Harmony Books, 1993. 40 Hsu HY. Treating cancer with Chinese herbs. Los Angeles: Oriental Healing Arts Institute, 1982. 41 Lau BH, Ruckle HC, Botolazzo T, Lui PD. Chinese medicinal herbs inhibit growth of murine renal cell carcinoma. Cancer Biother 1994; 9: 153– 61. 42 Burzynski S, Kubove E. Initial clinical study with antineo-plaston A2 injections in cancer patients with five years' follow-up. Drugs Exp Clin Res 1987; 13S: 1. 43 Green S. Antineoplastons: an unproved cancer therapy. JAMA 1992; 267: 2924– 8. 44 Moss RW. Cancer therapy: the independent consumer's guide. New York: Equinox Press, 1992. 45 American Cancer Society. Immuno-augmentative therapy (IAT). CA 1991; 41: 357– 64. 46 Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992; 3: 65– 71. 47 American Cancer Society. Shark cartilage/angiogenesis. Atlanta: American Cancer Society, 1992, Report no. 8100. 48 Prudden J. The treatment of human cancer with agents prepared from bovine cartilage. J Biol Response Modif 1985; 4: 551– 84. 49 Kriegel C, White K, Sculti L. Alternative cancer medicine: can your patients benefit? Alt Comp Ther 1994, October, pp 1– 7. 50 Lee A, Langer R. Shark cartilage contains inhibitors of tumor angiogenesis. Science 1983; 221: 1185– 7. 51 Butler K. A consumer's guide to alternative medicine. Buffalo, NY: Prometheus Books, 1992. 52 Jaroff L. A no-touch therapy. Time 1994, November 21, pp 88– 9. 53 Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, et al. Rapidly progressing interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341: 387– 91. 54 Gordon DW, Rosenthal G, Hart J, Sirota D, Baker AL. Chaparral ingestion: the broadening spectrum of liver injury caused by herbal medications. JAMA 1995; 273: 489– 90. 55 Hill CS. The barriers to adequate pain management with opioid analgesics. Semin Oncol 1993; 20(2 Suppl 1): 1– 5. 56 Cassileth BR, Lusk EJ, Guerry D, Blake AD, Walsh WP, Kascius L, et al. Survival and quality of life among patients on unproven versus conventional cancer therapy. N Engl J Med 1991; 324: 1180– 5. 57 Hoke F. Scientists see broad attack against research and reason. Scientist 1995, July 10, p 1. 58 Burnham S. A book of angels. New York: Ballantine Books, 1990. 59 Sagan C. What TV could do for America. Parade 1995, June 4, pp 12– 4. 60 Mack JF. Abduction: human encounters with aliens. New York: Charles Scribner's Sons, 1994. 61 Park RL. The danger of voodoo science. New York Times 1995, July 9, Op-Ed Page. Citing Literature Volume77, Issue615 March 1996Pages 1026-1034 ReferencesRelatedInformation
Referência(s)